Drugs & Targets FDA draft guidance encourages inclusion of male patients in breast cancer clinical trials September 06, 2019Vol.45 No.33
Drugs & Targets FDA approves darolutamide for non-metastatic castration-resistant prostate cancer August 02, 2019Vol.45 No.31
Drugs & Targets FDA grants breakthrough designation for NKTR-214 in combination with nivolumab for melanoma August 02, 2019Vol.45 No.31
Drugs & Targets EMA adopts positive opinion for Keytruda + Inlyta as first-line for RCC August 02, 2019Vol.45 No.31
Drugs & Targets Predictive Oncology, UPMC partner to establish AI approach to ovarian cancer July 26, 2019Vol.45 No.30
Drugs & Targets FDA requests Allergan voluntarily recall some breast implants July 26, 2019Vol.45 No.30
Drugs & Targets Australian regulator conditionally OKs expanded uses for Keytruda July 19, 2019Vol.45 No.29
Drugs & Targets FDA approves expanded indication for FoundationOneCDx as a companion diagnostic for Lynparza July 12, 2019Vol.45 No.28
